| Document Date: 2013-09-11 12:21:04
Open Document File Size: 156,56 KBShare Result on Facebook
City London / / Company Clinical Priorities Advisory Group / / / Facility University of Birmingham / / IndustryTerm non-invasive technology / radiotherapy technologies / / MedicalCondition ocular melanomas / non functioning adenomas / surgically refractory pituitary adenomas / uveal melanoma / tumor / previously operated adenomas / neovascular glaucoma / adenomas / Malignant and metastatic tumours / disease / Cataracts / prolactinoma / pituitary adenoma / retinal detachment / metastasis / macroprolactinomas / Ocular Melanoma / Recurrent adenomas / stroke / tumour / brain tumours / melanomas / melanoma / local tumor / residual pituitary adenomas / pituitary adenomas / growth hormone secreting adenomas / radiosurgery / arteriovenous malformations / arteriovenous malformations / local long-term tumor / benign tumours / tumours / / MedicalTreatment invasive surgery / radiation treatment / radiation therapy / radiosurgery / radiation treatments / Intensity Modulated Radiotherapy / open surgery / incisions / Stereotactic Radiosurgery / Radiotherapy / Gamma knife radiosurgery / surgery / radiation / / Organization N/A N/A N/A N/A Donna Hakes Medical Directorate / NHS / University of Birmingham / Medical Directorate / / Person Rama P. Gamma / Arch Clin Exp / / / Position Author Various / General / / Product ACTH / / ProvinceOrState Oregon / / Technology radiation / non-invasive technology / non SRS radiotherapy technologies / /
SocialTag |
Interim Clinical Commissioning Policy Statement: Stereotactic Radiosurgery / Radiotherapy for Ocular Melanoma and Pituitary Adenoma September 2013